NRI.TO - Nuvo Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue27,03920,49513,05718,409
Cost of Revenue12,77411,03613,58811,796
Gross Profit14,2659,459-5316,613
Operating Expenses
Research Development----
Selling General and Administrative6,6772,64512,97810,116
Non Recurring----
Total Operating Expenses19,45113,68126,56621,912
Operating Income or Loss7,5886,814-13,509-3,503
Income from Continuing Operations
Total Other Income/Expenses Net-1791,52152,118-6,758
Earnings Before Interest and Taxes7,5886,814-13,509-3,503
Interest Expense---713-649
Income Before Tax7,4098,33538,609-10,261
Income Tax Expense-719117
Minority Interest----
Net Income From Continuing Ops7,4098,32838,590-10,378
Non-recurring Events
Discontinued Operations-3,180-15,448-15,448-15,448
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,229-7,12038,590-10,378
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,229-7,12038,590-10,378